STOCK TITAN

[Form 4] Revvity, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Revvy, Inc. insider filing (Form 4) reports a stock option grant to Victor Miriame, Senior Vice President and Chief Commercial Officer. The filing shows a non-qualified stock option to purchase 32,382 shares of Revvity common stock at an exercise price of $90.465 per share. The transaction date is 08/15/2025 and ownership is direct. The option has a seven-year term and is scheduled to fully vest on the third anniversary of the grant, indicating vesting completes three years after the grant date. The form was signed by a power of attorney on behalf of the reporting person.

La comunicazione interna di Revvy, Inc. (Modello 4) segnala l'assegnazione di un'opzione su azioni a Victor Miriame, Senior Vice President e Chief Commercial Officer. Dal documento risulta un'opzione non qualificata per l'acquisto di 32.382 azioni ordinarie Revvity al prezzo di esercizio di $90,465 per azione. La data della transazione è il 15/08/2025 e la partecipazione è di tipo diretto. L'opzione ha una durata di sette anni e si prevede che venga totalmente maturata al terzo anniversario della concessione, cioè tre anni dopo la data del grant. Il modulo è stato firmato da un procuratore in rappresentanza del soggetto segnalante.

La declaración de insider de Revvy, Inc. (Formulario 4) informa sobre la concesión de una opción sobre acciones a Victor Miriame, Senior Vice President y Chief Commercial Officer. El documento muestra una opción no calificada para comprar 32.382 acciones ordinarias de Revvity a un precio de ejercicio de $90,465 por acción. La fecha de la operación es el 15/08/2025 y la titularidad es directa. La opción tiene un plazo de siete años y está programada para consolidarse completamente en el tercer aniversario de la concesión, es decir, tres años después de la fecha del otorgamiento. El formulario fue firmado por un apoderado en nombre de la persona que informa.

Revvy, Inc.의 내부자 보고서(Form 4)는 수석 부사장 겸 최고 상업 책임자인 Victor Miriame에게 주식매수선택권이 부여되었음을 보고합니다. 서류에는 Revvity 보통주 32,382주를 주당 $90.465의 행사가격으로 매수할 수 있는 비공인 주식옵션이 기재되어 있습니다. 거래일은 2025-08-15이며 보유 형태는 직접입니다. 옵션의 유효기간은 7년이며 부여일로부터 3주년(부여 후 3년)에 완전히 권리가 성취되도록 예정되어 있습니다. 해당 양식은 보고인 대신 권한을 위임받은 사람이 서명했습니다.

La déclaration d'initié de Revvy, Inc. (Formulaire 4) signale l'octroi d'une option sur actions à Victor Miriame, Senior Vice President et Chief Commercial Officer. Le document indique une option non qualifiée permettant d'acheter 32 382 actions ordinaires Revvity à un prix d'exercice de 90,465 $ par action. La date de la transaction est le 15/08/2025 et la détention est directe. L'option a une durée de sept ans et doit être entièrement acquise au troisième anniversaire de l'attribution, soit trois ans après la date de la remise. Le formulaire a été signé par un mandataire au nom de la personne déclarante.

Die Insider-Meldung von Revvy, Inc. (Formular 4) berichtet über die Gewährung einer Aktienoption an Victor Miriame, Senior Vice President und Chief Commercial Officer. Das Formular weist eine nicht qualifizierte Aktienoption zum Kauf von 32.382 Stück Revvity-Stammaktien zu einem Ausübungspreis von $90,465 je Aktie aus. Das Transaktionsdatum ist der 15.08.2025 und das Eigentum ist direkt. Die Option hat eine Laufzeit von sieben Jahren und soll vollständig am dritten Jahrestag der Gewährung vesten, also drei Jahre nach dem Zuteilungsdatum. Das Formular wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

Positive
  • Detailed disclosure provided: exercise price, share amount, grant date, vesting schedule and term are all reported.
  • Alignment with long-term incentives: option fully vests on the third anniversary, supporting multi-year retention.
  • Direct ownership disclosed: the filing specifies the shares are held directly by the reporting person.
Negative
  • None.

Insights

TL;DR: Routine executive option grant with time-based vesting; standard long-term incentive structure.

This Form 4 discloses a time-based non-qualified stock option for 32,382 shares at a $90.465 exercise price granted to the company's Senior Vice President, Chief Commercial Officer. The option carries a seven-year term and fully vests on the third anniversary of grant, consistent with common executive retention incentives that align management and shareholder interests over multiple years. Reporting is direct and filed under Section 16; the disclosure is complete for the reported transaction.

TL;DR: Filing appears procedurally correct; no unusual codes or derivatives beyond a standard NQ option.

The Form 4 uses transaction code indicating acquisition (A) of a non-derivative option position underlying 32,382 shares. The filing provides the exercise price, term, vesting schedule description and direct ownership designation. The signature block shows a power of attorney executed filing on 08/18/2025. From a compliance perspective, the required details to satisfy Section 16 reporting appear included in this document.

La comunicazione interna di Revvy, Inc. (Modello 4) segnala l'assegnazione di un'opzione su azioni a Victor Miriame, Senior Vice President e Chief Commercial Officer. Dal documento risulta un'opzione non qualificata per l'acquisto di 32.382 azioni ordinarie Revvity al prezzo di esercizio di $90,465 per azione. La data della transazione è il 15/08/2025 e la partecipazione è di tipo diretto. L'opzione ha una durata di sette anni e si prevede che venga totalmente maturata al terzo anniversario della concessione, cioè tre anni dopo la data del grant. Il modulo è stato firmato da un procuratore in rappresentanza del soggetto segnalante.

La declaración de insider de Revvy, Inc. (Formulario 4) informa sobre la concesión de una opción sobre acciones a Victor Miriame, Senior Vice President y Chief Commercial Officer. El documento muestra una opción no calificada para comprar 32.382 acciones ordinarias de Revvity a un precio de ejercicio de $90,465 por acción. La fecha de la operación es el 15/08/2025 y la titularidad es directa. La opción tiene un plazo de siete años y está programada para consolidarse completamente en el tercer aniversario de la concesión, es decir, tres años después de la fecha del otorgamiento. El formulario fue firmado por un apoderado en nombre de la persona que informa.

Revvy, Inc.의 내부자 보고서(Form 4)는 수석 부사장 겸 최고 상업 책임자인 Victor Miriame에게 주식매수선택권이 부여되었음을 보고합니다. 서류에는 Revvity 보통주 32,382주를 주당 $90.465의 행사가격으로 매수할 수 있는 비공인 주식옵션이 기재되어 있습니다. 거래일은 2025-08-15이며 보유 형태는 직접입니다. 옵션의 유효기간은 7년이며 부여일로부터 3주년(부여 후 3년)에 완전히 권리가 성취되도록 예정되어 있습니다. 해당 양식은 보고인 대신 권한을 위임받은 사람이 서명했습니다.

La déclaration d'initié de Revvy, Inc. (Formulaire 4) signale l'octroi d'une option sur actions à Victor Miriame, Senior Vice President et Chief Commercial Officer. Le document indique une option non qualifiée permettant d'acheter 32 382 actions ordinaires Revvity à un prix d'exercice de 90,465 $ par action. La date de la transaction est le 15/08/2025 et la détention est directe. L'option a une durée de sept ans et doit être entièrement acquise au troisième anniversaire de l'attribution, soit trois ans après la date de la remise. Le formulaire a été signé par un mandataire au nom de la personne déclarante.

Die Insider-Meldung von Revvy, Inc. (Formular 4) berichtet über die Gewährung einer Aktienoption an Victor Miriame, Senior Vice President und Chief Commercial Officer. Das Formular weist eine nicht qualifizierte Aktienoption zum Kauf von 32.382 Stück Revvity-Stammaktien zu einem Ausübungspreis von $90,465 je Aktie aus. Das Transaktionsdatum ist der 15.08.2025 und das Eigentum ist direkt. Die Option hat eine Laufzeit von sieben Jahren und soll vollständig am dritten Jahrestag der Gewährung vesten, also drei Jahre nach dem Zuteilungsdatum. Das Formular wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Victor Miriame

(Last) (First) (Middle)
77 4TH AVENUE

(Street)
WALTHAM MA 02451-7567

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
REVVITY, INC. [ RVTY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Please See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
NQ Stock Option (right to buy) $90.465 08/15/2025 A 32,382 (1) 08/15/2032 Common Stock 32,382 $0 32,382 D
Explanation of Responses:
1. This option is scheduled to fully vest on the third anniversary of the date of grant and has a 7-year term.
Remarks:
Senior Vice President, Chief Commercial Officer
/s/ John L. Healy (POA on file) for Miriame Victor 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Victor Miriame acquire in the Form 4 filed for RVTY?

The filing reports acquisition of a non-qualified stock option to purchase 32,382 shares of Revvity common stock.

What is the exercise price and term for the option reported on Form 4 for RVTY?

The option has an exercise price of $90.465 per share and a seven-year term.

When was the transaction date and when does the option fully vest?

The transaction date is 08/15/2025 and the option is scheduled to fully vest on the third anniversary of the grant.

What is Victor Miriame's role at Revvity as shown in the filing?

The remarks state the reporting person is Senior Vice President, Chief Commercial Officer.

Who signed the Form 4 and when was it signed?

The form was signed by John L. Healy (POA on file) on 08/18/2025 on behalf of Victor Miriame.
Revvity Inc

NYSE:RVTY

RVTY Rankings

RVTY Latest News

RVTY Latest SEC Filings

RVTY Stock Data

10.61B
115.66M
0.35%
100.65%
5.07%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
WALTHAM